Glycated hemoglobin HbA1C and diagnosis of diabetes mellitus. Opinions and perspectives.
Authors:
B. Friedecký; J. Kratochvíla
Authors place of work:
SEKK spol. s r. o. Pardubice
Published in the journal:
Klin. Biochem. Metab., 21 (42), 2013, No. 3, p. 135-138
Category:
Zaujalo nás
Summary
Outline of the current literature on the measurement and units of glycated hemoglobin HbA1C, about possibilities and limits of use of the analyte in the diagnosis of diabetes mellitus and about implementation of international and national recommendations (guidelines).
Zdroje
1. Florkowski G. M., Crooke M. J. Glycated haemoglobin A1C and diagnosis of diabetes. Ann. Clin. Biochem., 2012, 49, p. 509.
2. John W. G. Use of HbA1C in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance11. Diabet. Med. 2012, 29, p. 1350-1357.
3. Webová adresa: http://www.who.int (dostupné k 11. 6. 2013).
4. Webová adresa: http://practicaldiabetes.com (dostupné k 11. 6. 2013).
5. The National Academy of Clinical Biochemistry. Laboratory Medicine Practical Guidelines. Guidelines and recomendations for laboratory analysis in the diagnosis and management of diabetes mellitus. NACB. 2011.
6. American Diabetes Association. Clinical Practice Re-commendations 2011. Diabet. Care, 2011, 34, Suppl 1, p. 4-11.
7. Schleicher E. Neue Karriere eines Biomarkers. Trillium report. 2012, 10, 14-15 a webová adresa www.diaprof.org (dostupné k 11. 6. 2013).
8. Lippi G., Targter G. Haemoglobin A1C and diagnosis of diabetes not ready for the prime time? Ann. Clin. Biochem., 2012, 49, p. 508.
9. Hanas R., John G. W. 2010 Consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabet. Care, 2010, 33, p. 1903-1904. nebo Clin. Chem., 2010, 56, p. 1362-4.
10. Doporučení ČSKB ČLS JEP a ČDS ČLS JEP. Diabetes mellitus - laboratorní diagnostika a sledování stavu pacientů. Dostupné na http://www.cskb.cz (dostupné k 11. 6. 2013).
11. Sacks D. B. Measurement of Hemoglobin A1C. Diabet. Care, 2012, 35, p. 2674-2680.
12. Cefalu W. T., Kirkman M. S. New twist in Diabetes Care for HbA1C reporting:“It takes two to tango“. Diabet. Care, 2012, 35, p. 2015-2016.
13. Mosca A., Lapolla A., Gillery P. Glycemic control in the clinical management of diabetic patients. Clin. Chem. Lab. Med., 2012, 12, p. 1-14.
14. Weykamp C. W., Mosca A., Gillery P., Panteghini M. The analytical goals for hemoglobin A1C measurement in IFCC units and National Glycohemoglobin Standardization Program units are different. Clin. Chem., 2011, 57, 8, p. 1204-1206.
15. Lenters-Westra E., Weykamp C., Schindteln R. K. et al. One of five laboratories using various hemoglobin A1C methods do not meet criteria for optimal diabetes care management. Diabetes. Technol. Ther., 2011, 13, p. 429-433.
16. Kaiser P., Reinauer H. Diabetes mellitus: The long way of standardization of HbA1C to the level of high test metrological order. Ger. Med. Sci., 2011, Doc 28.
17. Webová adresa: http://www.dgkl-rfb.de:81/index.shtml (Dostupné 11.6.2013)
18. Braga F., Panteghini M. Standardization and analytical goals for glycated hemoglobin measurement. Clin. Chem. Lab. Med., 2013 DOI 10.1515/cclm-2013-0060 in press.
19. Friedecký B., Kratochvíla J. SKUP – cesta ke zvýšení kvality péče o pacienty. Prakt. Lék., 2012,10, p. 492-494.
20. Leca V., Ibrahim Z., Lombart-Pombon E. et al. Point-of-Care measurements of HbA1C: Simplicity does not mean laxity with controls. Diabet. Care, 2012, 35, e85.
21. Laiteerapong N., John P. M., Nathan A. G. Public health implications of recommendations to individualize glycemis targets in adults with diabetes. Diabet. Care, 2013, 36, p. 84-88.
22. Cohen R. M., Lindsell C. J. When the blood glucose and the HbA1C don´t match:Turning uncertainty into opportunity. Diabet. Care, 2012, 35, p. 2421-2423.
23. Rodriguez-Segarde S., Casanueva F. F., Rodriguiz J. et al. Estimation of the glycation gap in diabetic patients with stable glycemic control. Diabet. Care, 2012, 35, p. 2447-2450.
Štítky
Biochemie Nukleární medicína Nutriční terapeutČlánek vyšel v časopise
Klinická biochemie a metabolismus
2013 Číslo 3
- Farmakologická léčba obezity u pacientek se syndromem polycystických ovarií – systematický přehled a klinická doporučení
- Efektivita léčby a možné indikace liraglutidu v gynekologii
- Zpracované masné výrobky a červené maso jako riziko rozvoje kolorektálního karcinomu u žen? Důkazy z prospektivní analýzy
- GLP-1RA a PCOS: Je to „jenom“ o hmotnosti?
Nejčtenější v tomto čísle
- Intoxikace vitaminem D – kazuistika
- Glykovaný hemoglobin HbA1C a diagnóza diabetu mellitu. Názory a perspektiva.
- Struktura, funkce a medicínský význam lipokalinů
- Abstrakta posterů